Embodiments of the present invention relate to medical devices and the simultaneous delivery of diagnostic and therapeutic treatments. More specifically, embodiments of the present invention relate to devices and methods for delivery of cardiovascular diagnostic or pacing therapy in a magnetic field environment.
Magnetic resonance imaging (MRI) is a non-invasive imaging method that utilizes nuclear magnetic resonance techniques to render images within a patient's body. Typically, MRI systems employ the use of a magnetic coil having a magnetic field strength of between about 0.2 to 3 Teslas. During the procedure, the body tissue is briefly exposed to RF pulses of electromagnetic energy in a plane perpendicular to the magnetic field. The resultant electromagnetic energy from these pulses can be used to image the body tissue by measuring the relaxation properties of the excited atomic nuclei in the tissue.
During imaging, the electromagnetic radiation produced by the MRI system may be picked up by implantable device leads used in implantable medical devices such as pacemakers or cardiac defibrillators. This energy may be transferred through the lead to the electrode in contact with the tissue, which may lead to elevated temperatures at the point of contact. The degree of tissue heating is typically related to factors such as the length of the lead, the conductivity or impedance of the lead, and the surface area of the lead electrodes. Exposure to a magnetic field may also induce an undesired voltage in the lead.
Accordingly, there is an ongoing need for devices and methods for shielding medical devices from magnetic fields during medical procedures such as magnetic resonance imaging (MRI).
According to embodiments of the present invention, a filter circuit electrically connected in series between the lead conductor and the electrode includes a band pass filter which attenuates signals having a frequency other than a natural resonance frequency. According to such embodiments, the pulse generator transmits therapy signals to the electrode as a sinusoidal voltage wave at the natural resonance frequency. The band pass filter permits therapy voltage signals at the natural resonance frequency to pass through to the electrode, while blocking MRI-induced voltage signals which are at frequencies different from the natural frequency, according to embodiments of the present invention. The filter circuit may also include a rectifier circuit, such as a diode, to rectify the sinusoidal voltage wave at the natural frequency into a direct current signal for the electrode.
While some embodiments are disclosed, still other embodiments of the present invention will become apparent to those skilled in the art from the following detailed description, which shows and describes illustrative embodiments of the invention. Accordingly, the drawings and detailed description are to be regarded as illustrative in nature and not restrictive.
While the invention is amenable to various modifications and alternative forms, specific embodiments have been shown by way of example in the drawings and are described in detail below. The intention, however, is not to limit the invention to the particular embodiments described. On the contrary, the invention is intended to cover all modifications, equivalents, and alternatives falling within the scope of the appended claims.
As shown in
The band pass filter 47 attenuates (e.g. blocks) frequencies except for a natural resonance frequency, f0. The natural resonance frequency f0 in hertz may be found with the following equation:
where L is the inductance of the inductor 51 in Henries, and C is the capacitance of the capacitor 50 in Farads. For filter circuits 44 which include a band pass filter 47 but which do not include a rectifier circuit 48 between the lead conductor 46 and electrode 42, the natural resonance frequency of the circuit 44 may be determined with (EQ. 1). When additional components are added between the band pass filter 47 and the electrode 42, such as, for example, inductor 53 and capacitor 54, the equation for calculating the natural resonance frequency of the circuit 44 changes. Based on the disclosure herein, one of ordinary skill in the art will recognize that the natural resonance frequency for any given circuit 44 may also be determined empirically through circuit 44 testing and/or simulation. As used herein, the term “band pass filter” is used in its broadest sense to refer to all circuitry between the lead conductor 46 and the electrode 42 that cooperates to attenuate signals passing through the circuit 44. Thus, although the band pass filter 47 of
According to some embodiments of the present invention, the band pass filter 47 attenuates signals at frequencies other than the natural resonance frequency by blocking such signals. According to other embodiments of the present invention, the band pass filter 47 attenuates signals at frequencies other than the natural resonance frequency by weakening such signals or reducing their amplitude without completely blocking them. According to some embodiments of the present invention, the band pass filter 47 attenuates signals at frequencies closer to the natural resonance frequency to a lesser degree than signals at frequencies further from the natural resonance frequency.
According to some embodiments of the present invention, a natural resonance frequency range exists. Signals in the natural resonance frequency range still have enough power to adequately provide therapy through the electrode 42 after passing through the band pass filter 47, but the natural resonance frequency range excludes frequencies at which signals are generated by an MRI system. According to such embodiments, the band pass filter 47 still substantially shields MRI signals between the lead conductor 46 and the electrode 42, while permitting transmission of therapy signals to the electrode 42 through the band pass filter 47 by a range of signal frequencies that are not exactly at the natural resonance frequency. Based on the disclosure provided herein, one of ordinary skill in the art will recognize that selection of such a natural resonance frequency range may depend on a number of factors, including hardware selection for the filter circuit 44 and therapy requirements.
When electromagnetic radiation from an MRI system is picked up by the implantable device leads 14, and more specifically by the lead conductor 46, the energy may be transferred through the lead conductor 46 and into the electrode 42, which is in contact with tissue, which may lead to elevated temperature at the point of contact. The induced voltage in the lead conductor 46 may also potentially disrupt the functionality of the pulse generator 12 and/or lead electrode 42. However, the radiofrequency energy of electromagnetic wave and lower frequency voltage induced by an MRI gradient field in the lead conductor 46 can be filtered out by using the filter circuit 44, and more specifically by using the band pass filter 47, according to embodiments of the present invention.
In some embodiments, resistor 49 is a high impedance resistor. As an example, the impedance of the resistor 49 is high enough to prevent electromagnetic energy picked up by the lead conductor 46 from transferring to the surrounding tissue via the electrode 42. However, the impedance of the resistor 49 is low enough to provide a conductive path between the pulse generator 12 and a common ground to permit sensing applications which might otherwise be inhibited by the inclusion of the band pass filter 47, at the electrode 42, according to embodiments of the present invention.
As illustrated in
Although
Various modifications and additions can be made to the exemplary embodiments discussed without departing from the scope of the present invention. For example, while the embodiments described above refer to particular features, the scope of this invention also includes embodiments having different combinations of features and embodiments that do not include all of the described features. Accordingly, the scope of the present invention is intended to embrace all such alternatives, modifications, and variations as fall within the scope of the claims, together with all equivalents thereof.
This application claims the benefit of U.S. Provisional Patent Application Ser. No. 61/027,753, filed on Feb. 11, 2008, and entitled, “MRI SHIELDING IN ELECTRODES USING AC PACING,” which is incorporated by reference herein in its entirety for all purposes.
Number | Date | Country | |
---|---|---|---|
61027753 | Feb 2008 | US |